Back
Innate Pharma SA Vs. Root Industry Stock Comparison
Buy
54
IPHA
Innate Pharma SA
Last Price:
$2.02
Seasonality Move:
1.21%
Buy
83
ROOT
Root
Last Price:
$152.07
Seasonality Move:
13.8%
Buy
54
Innate Pharma SA (IPHA)
is a Buy
Is Innate Pharma SA a Buy, Sell or Hold?
-
The current Innate Pharma SA [IPHA] share price is $2.02. The Score for IPHA is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
IPHA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.02The current trend is moderately bearish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ROOT Stock Price Chart
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 48.63 | Sell |
Chaikin Money Flow: | 1498 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
ROOT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.69 | Buy |
Relative Strength Index (14 RSI): | 64.6 | Buy |
Chaikin Money Flow: | 1140316 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.04 | Sell |
20-day SMA: | 2.11 | Sell |
50-day SMA: | 1.94 | Buy |
200-day SMA: | 2.07 | Sell |
8-day EMA: | 2.04 | Sell |
20-day EMA: | 2.05 | Sell |
50-day EMA: | 1.99 | Buy |
200-day EMA: | 2.08 | Sell |
ROOT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 137.59 | Buy |
20-day SMA: | 126.37 | Buy |
50-day SMA: | 103.59 | Buy |
200-day SMA: | 69.6 | Buy |
8-day EMA: | 137.15 | Buy |
20-day EMA: | 126.75 | Buy |
50-day EMA: | 109.94 | Buy |
200-day EMA: | 75.85 | Buy |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Root Earnings Growth & ROOT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.83 per share, an increase next quarter of $0.41 per share, a decrease this year of $0.33 per share, and an increase next year of $2.11 per share.
Innate Pharma SA Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Root Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |